Cookie Preference

This website uses cookies to improve user experience. Please select an option.  Privacy Policy

No cookies except for those necessary for technical reasons are set.

Startups 2019

Emerging Startups

ADCendo

ADCendo is a startup company based on an antibody-drug-conjugate, which is capable of curing cancer in a mouse model of disease

Eximmium

Eximmium generates novel therapeutic antibodies for the comprehensive treatment of cancer.

FerroSens GmbH

FerroSens offers the world’s first non-invasive screening device for iron deficiency at the point-of-care.

ImmuCon

ImmuCon develops a proprietary “first-in class” monoclonal antibody against IL-3 for treatment of patients with systemic lupus erythematosus (SLE).

Isanans Pharma

Isanans Pharma is working for improved vision

ISD-Immunotech ApS

ISD is developing a first-in-class peptide therapy for severe systemic lupus erythematosus (SLE) targeting  STimulator of INterfereon Genes (STING)

Rising Startups

Mindpax GmbH

Digital therapy for bipolar disorder and schizophrenia.

Pluvia

Giving PKU patients a shot at normal life

UGISense AG

UGISense uses its platform technology to develop antisense drugs in collaboration with industrial partners.

VALANX Biotech GmbH

Superpowering proteins.

Posters

aBACTER - TU Munich

aBACTER is an innovative project team focused on the development of novel antibiotics exhibiting excellent potency against WHO-priority pathogens.

BioReperia

Our vision is to reduce cancer mortality by predicting the most efficient cancer treatments for individual patients and to accelerate drug discovery.

Epimune GmbH

Pioneering epigenetic immune cell diagnostics

NC Biomatrix b.v.

Providing new injectable biomatrix to treat early stage disc degeneration as well as early osteoarthritis in the knee and hip.

PixelBiotech GmbH

We are democratizing the genetic testing via HuluFISH technology.

Silvacx

Silvacx is an emerging startup developing rationally designed, nanoparticle-based immunotherapeutics against cancer and infectious diseases.

Tubulis

Reimagining ADCs: Expanding Therapeutic Opportunities and Capturing Unexplored Value.